Clinical Trial Update: Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

This document summarizes the completion of a Phase 2/3 trial evaluating the addition of disulfiram to standard chemotherapy for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Disulfiram (Antabuse) (disulfiram)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Non-small Cell Lung Cancer | Phase 2, Phase 3 | Status: COMPLETED